CVS

CVS Earnings Preview

CVS Health Corporation · Healthcare · $99B

14d until earnings

CVS Earnings

Wednesday, May 06 2026
EPS Estimate
$2.21
$2.10 – $2.38
Revenue Estimate
$95.1B
Current Price
$76.58

Data Signal Summary

2 bullish
1 bearish
Insider buying cluster Put/call 0.3 (bullish skew) Price downtrend

Key Context

Analyst Consensus
mixed
Insider Activity
mixed
Price Trend
downtrend
From 52w High
-3.5%
P/E Ratio
55.7
Est. Revisions (30d)
-1.0% 2up/9dn
Analyst Target (mean)
$97 $79–$140 +26%
Options P/C Ratio
0.31
Est. Dispersion
13% 22 analysts
Insider Cluster
strong buy
Fund Convergence
strong D.E. Shaw, Citadel, Bridgewater

Recent Activity

insider trades 68 transactions
Award · MANDADI TILAK (Officer) ·22,277 shares ·$1,599,934
Award · SHAH PREM S (Officer) ·25,062 shares ·$1,799,953
Award · JOYNER JOHN DAVID (Chief Executive Officer) ·86,326 shares ·$6,199,933
Award · NELSON STEVEN H (Officer) ·22,277 shares ·$1,599,934
Award · KHICHI SAMRAT S (General Counsel) ·12,531 shares ·$899,976
63 more
Award · CAPOZZI HEIDI B ·10,025 shr ·$719,996
Award · COMPTON-PHILLIPS AMY ·5,569 shr ·$399,966
Award · CLARK JAMES DAVID ·11,138 shr ·$799,931
Award · NEWMAN BRIAN ·19,493 shr ·$1,399,987
Award · GALLINA JOHN E ·582 shr ·$41,823
Award · FINUCANE ANNE A ·591 shr ·$44,940
Award · KIRBY JOHN SCOTT ·1,652 shr ·$125,618
Award · BROWN C DAVID II ·1,775 shr ·$134,971
Award · AGUIRRE FERNANDO ·1,800 shr ·$136,872
Award · SANSONE GUY P ·1,652 shr ·$125,618
Award · NORWALK LESLIE V ·1,652 shr ·$125,618
Award · SHULMAN DOUGLAS H ·1,652 shr ·$125,618
Award · BALSER JEFFREY R M.D., PH.D. ·1,775 shr ·$134,971
Sell · FINUCANE ANNE A ·7,500 shr ·$532,650
Buy · SANSONE GUY P ·1,570 shr ·$100,009
Award · COMPTON-PHILLIPS AMY ·53,091 shr ·$3,399,948
Award · NEWMAN BRIAN ·21,861 shr ·$1,399,978
Award · FINUCANE ANNE A ·692 shr ·$41,845
Award · KIRBY JOHN SCOTT ·2,769 shr ·$167,441
Award · BROWN C DAVID II ·2,232 shr ·$134,969
Award · AGUIRRE FERNANDO ·2,263 shr ·$136,844
Award · SANSONE GUY P ·2,077 shr ·$125,596
Award · MAHONEY MICHAEL F ·144 shr ·$8,708
Award · NORWALK LESLIE V ·2,077 shr ·$125,596
Award · SHULMAN DOUGLAS H ·2,077 shr ·$125,596
Award · BALSER JEFFREY R M.D., PH.D. ·2,232 shr ·$134,969
Sell · ROBBINS LARRY ·3,750,000 shr ·$253,695,413
Award · MANDADI TILAK ·20,594 shr ·$1,399,980
Award · SHAH PREM S ·26,478 shr ·$1,799,974
Award · NELSON STEVEN H ·21,329 shr ·$1,449,945
Award · KHICHI SAMRAT S ·16,181 shr ·$1,099,984
Award · CAPOZZI HEIDI B ·11,768 shr ·$799,989
Award · COWHEY THOMAS F. ·16,181 shr ·$1,099,984
Award · CLARK JAMES DAVID ·14,710 shr ·$999,986
Exercise · SHAH PREM S ·846 shr ·$52,630
Sell · CLARK JAMES DAVID ·7,513 shr ·$498,488
Exercise · CLARK JAMES DAVID ·7,513 shr ·$467,384
Buy · MAHONEY MICHAEL F ·30,000 shr ·$2,001,000
Buy · NELSON STEVEN H ·24 shr ·$1,289
Other · FINUCANE ANNE A ·2,665 shr ·$151,532
Award · MANDADI TILAK ·50,125 shr ·$2,999,981
Award · FARAH ROGER N ·50,125 shr ·$2,999,981
Award · CAPOZZI HEIDI B ·83,542 shr ·$4,999,989
Award · DEPARLE NANCY-ANN M. J.D. ·2,331 shr ·$133,100
Award · KIRBY JOHN SCOTT ·2,933 shr ·$167,474
Award · MILLON JEAN PIERRE ·2,200 shr ·$125,620
Award · BROWN C DAVID II ·2,331 shr ·$133,100
Award · AGUIRRE FERNANDO ·2,364 shr ·$134,984
Award · SANSONE GUY P ·2,200 shr ·$125,620
Award · MAHONEY MICHAEL F ·2,200 shr ·$125,620
Award · NORWALK LESLIE V ·2,200 shr ·$125,620
Award · SHULMAN DOUGLAS H ·2,200 shr ·$125,620
Award · BALSER JEFFREY R M.D., PH.D. ·2,375 shr ·$135,612
Buy · CAPOZZI HEIDI B ·80 shr ·$4,589
Award · DEPARLE NANCY-ANN M. J.D. ·2,314 shr ·$133,101
Award · KIRBY JOHN SCOTT ·2,912 shr ·$167,498
Award · MILLON JEAN PIERRE ·2,314 shr ·$133,101
Award · BROWN C DAVID II ·2,314 shr ·$133,101
Award · AGUIRRE FERNANDO ·2,347 shr ·$134,999
Award · MAHONEY MICHAEL F ·2,184 shr ·$125,624
Award · BALSER JEFFREY R M.D., PH.D. ·2,184 shr ·$125,624
Buy · LUDWIG EDWARD J. ·1,000 shr ·$53,879
Buy · MAHONEY MICHAEL F ·9,181 shr ·$500,294
analyst ratings 1 rating
Baird Outperform 6d ago